Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other infections, today announced it will be participating in the Wedbush PacGrow 2015 Healthcare Conference. Jeff Stein, Ph.D., president and chief executive officer of Cidara, is scheduled to present at 12:45 p.m. EDT (9:45 a.m. PDT) on Wednesday, August 12, 2015 in New York. Cidara Therapeutics, Inc. (NASDAQ:CDTX) belongs to Healthcare sector. Its weekly performance is 5.09%. On last trading day company shares ended up $14.25. Cidara Therapeutics, Inc. (NASDAQ:CDTX) distance from 50-day simple moving average (SMA50) is -4.93%.
Nektar Therapeutics (Nasdaq: NKTR) reported its financial results for the second quarter ended June 30, 2015. We are pleased that the MOVANTIK launch in the U.S. is off to an encouraging start with very rapid uptake,” said Howard W. Robin, President and Chief Executive Officer of Nektar. “AstraZeneca plans to launch MOVANTIK in both Europe and Canada in the second half of this year. The SUMMIT-07 efficacy study of NKTR-181 in patients with chronic low back pain is well underway and proceeding ahead of schedule. We recently signed an important clinical collaboration with MD Anderson Cancer Center for our immuno-oncology therapy, NKTR-214, which is scheduled to enter a Phase 1 / 2 clinical study before year-end. Finally, Baxalta’s ADYNOVATE, or BAX 855, continues on track to be approved and launched in the U.S. by the end of 2015. Nektar Therapeutics (NASDAQ:NKTR) shares fell -4.63% in last trading session and ended the day at $11.73. NKTR Gross Margin is 90.00% and its return on assets is 5.50%. Nektar Therapeutics (NASDAQ:NKTR) quarterly performance is 3.62%.
DLH Holdings(NASDAQ:DLHC) announced the earnings results for Fiscal Year 2015 and Q3. The results came in during Pre-market on Aug 6, 2015. Earnings per share were $0.04. DLH Holdings Corp. (NASDAQ:DLHC) ended the last trading day at $2.73. Company weekly volatility is calculated as 6.81% and price to cash ratio as 6.21. DLH Holdings Corp. (NASDAQ:DLHC) showed a weekly performance of -10.78%.
Nokia Corporation (ADR) (NYSE:NOK) has confirmed to TechRadar that the demo online shop with its branding is in no way connected to itself, and it has no plans to launch the Nokia N1 tablet in any new countries yet. A spokesperson told us: “The online store referenced in the GSMArena.com report is not affiliated to nor authorised by Nokia; We are investigating and will take whatever actions are necessary to protect our brand. On 06 August, Nokia Corporation (ADR) (NYSE:NOK) shares decreased -0.58% and was closed at $6.81. NOK EPS growth in last 5 year was 5.50%. Nokia Corporation (ADR) (NYSE:NOK) year to date (YTD) performance is -11.20%.